Fred H Rodriguez1,2,3,4, Georges Ephrem1,2, Jennifer F Gerardin1,2, Cheryl Raskind-Hood5, Carol Hogue5, Wendy Book1,2. 1. Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA. 2. Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. 3. Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA. 4. Sibley Heart Center Cardiology, Atlanta, Georgia, USA. 5. Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Abstract
OBJECTIVE: Although the ICD-9-CM code 745.5 is widely used to indicate the presence of a secundum atrial septal defect (ASD), it is also used for patent foramen ovale (PFO) which is a normal variant and for "rule-out" congenital heart disease (CHD). The ICD-10-CM code Q21.1 perpetuates this issue. The objective of this study was to assess whether code 745.5 in isolation or in combination with unspecified CHD codes 746.9 or 746.89 miscodes for CHD, and if true CHD positives decrease with age. DESIGN: Echocardiograms of patients with an ICD-9-CM code of 745.5 in isolation or in combination with unspecified CHD codes 746.9 or 746.89 were reviewed to validate the true incidence of an ASD. This observational, cross-sectional record review included patients between 11 and 64 years of age. RESULTS: Medical charts and echocardiograms of 190 patients (47.9% males) were reviewed. The number of falsely coded patients with 745.5 (no ASD) was high (76.3%). Forty-five (23.7%) patients had a true ASD. Among the 145 patients without an ASD, 100 (52.6%) were classified as having a PFO, 37 (19.5%) had a normal non-CHD echocardiogram, and 8 (4.2%) had some other CHD anomaly. The likelihood that 745.5 coded for a true ASD was higher in children aged 11-20 (64.3%) than adults aged 21-64 years (20.6%). CONCLUSIONS: This validation study demonstrates that 745.5 performed poorly across all ages. As 745.5 is widely used in population-level investigations and ICD-10-CM perpetuates the problem, future analyses utilizing CHD codes should consider separate analysis of those identified only through code 745.5.
OBJECTIVE: Although the ICD-9-CM code 745.5 is widely used to indicate the presence of a secundum atrial septal defect (ASD), it is also used for patent foramen ovale (PFO) which is a normal variant and for "rule-out" congenital heart disease (CHD). The ICD-10-CM code Q21.1 perpetuates this issue. The objective of this study was to assess whether code 745.5 in isolation or in combination with unspecified CHD codes 746.9 or 746.89 miscodes for CHD, and if true CHD positives decrease with age. DESIGN: Echocardiograms of patients with an ICD-9-CM code of 745.5 in isolation or in combination with unspecified CHD codes 746.9 or 746.89 were reviewed to validate the true incidence of an ASD. This observational, cross-sectional record review included patients between 11 and 64 years of age. RESULTS: Medical charts and echocardiograms of 190 patients (47.9% males) were reviewed. The number of falsely coded patients with 745.5 (no ASD) was high (76.3%). Forty-five (23.7%) patients had a true ASD. Among the 145 patients without an ASD, 100 (52.6%) were classified as having a PFO, 37 (19.5%) had a normal non-CHD echocardiogram, and 8 (4.2%) had some other CHD anomaly. The likelihood that 745.5 coded for a true ASD was higher in children aged 11-20 (64.3%) than adults aged 21-64 years (20.6%). CONCLUSIONS: This validation study demonstrates that 745.5 performed poorly across all ages. As 745.5 is widely used in population-level investigations and ICD-10-CM perpetuates the problem, future analyses utilizing CHD codes should consider separate analysis of those identified only through code 745.5.
Authors: Kayla N Anderson; Naomi K Tepper; Karrie Downing; Elizabeth C Ailes; Ginnie Abarbanell; Sherry L Farr Journal: Am Heart J Date: 2020-01-21 Impact factor: 4.749
Authors: Karrie F Downing; Naomi K Tepper; Regina M Simeone; Elizabeth C Ailes; Michelle Gurvitz; Sheree L Boulet; Margaret A Honein; Penelope P Howards; Anne M Valente; Sherry L Farr Journal: Circ Cardiovasc Qual Outcomes Date: 2020-06-08
Authors: Jennifer Gerardin; Cheryl Raskind-Hood; Fred H Rodriguez; Trenton Hoffman; Andreas Kalogeropoulos; Carol Hogue; Wendy Book Journal: Congenit Heart Dis Date: 2019-05-08 Impact factor: 2.007
Authors: Sherry L Farr; Catharine Riley; Alissa R Van Zutphen; Timothy J Brei; Vinita Oberoi Leedom; Russell S Kirby; Laura J Pabst Journal: Birth Defects Res Date: 2021-12-18 Impact factor: 2.661
Authors: M Jill Glidewell; Sherry L Farr; Wendy M Book; Lorenzo Botto; Jennifer S Li; Aida S Soim; Karrie F Downing; Tiffany Riehle-Colarusso; Alfred A D'Ottavio; Marcia L Feldkamp; Amber D Khanna; Cheryl L Raskind-Hood; Kristin M Sommerhalter; Tessa L Crume Journal: Am Heart J Date: 2021-05-03 Impact factor: 5.099
Authors: Michelle Gurvitz; Julie E Dunn; Ami Bhatt; Wendy M Book; Jill Glidewell; Carol Hogue; Angela E Lin; George Lui; Claire McGarry; Cheryl Raskind-Hood; Alissa Van Zutphen; Ali Zaidi; Kathy Jenkins; Tiffany Riehle-Colarusso Journal: J Am Coll Cardiol Date: 2020-07-14 Impact factor: 27.203
Authors: Sherry L Farr; Karrie F Downing; Elizabeth C Ailes; Michelle Gurvitz; Gretchen Koontz; Emmy L Tran; C J Alverson; Matthew E Oster Journal: J Am Heart Assoc Date: 2019-09-12 Impact factor: 5.501
Authors: Michal Benderly; Jonathan Buber; Ofra Kalter-Leibovici; Leonard Blieden; Alexander Dadashev; Avraham Lorber; Amiram Nir; Sergei Yalonetsky; Gabriel Chodick; Dahlia Weitzman; Ran Balicer; Efrat Mazor Dray; Havi Murad; Yaron Razon; Rafael Hirsch Journal: J Am Heart Assoc Date: 2021-01-12 Impact factor: 5.501
Authors: Tabassum Z Insaf; Kristin M Sommerhalter; Treeva A Jaff; Sherry L Farr; Karrie F Downing; Ali N Zaidi; George K Lui; Alissa R Van Zutphen Journal: Am Heart J Date: 2021-02-23 Impact factor: 5.099